Strategic Investment Solutions’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100
| Closed | -$879 | – | 694 |
|
|
2024
Q4 | $879 | Hold |
100
| – | – | ﹤0.01% | 567 |
|
|
2024
Q3 | $519 | Hold |
100
| – | – | ﹤0.01% | 569 |
|
|
2024
Q2 | $378 | Buy |
+100
| New | +$378 | ﹤0.01% | 567 |
|
|
2023
Q4 | $1.32K | Sell |
150
-3,000
| -95% | -$26.4K | ﹤0.01% | 990 |
|
|
2023
Q3 | $60.6K | Buy |
3,150
+3,100
| +6,200% | +$59.6K | ﹤0.01% | 599 |
|
|
2023
Q2 | $1.18K | Sell |
50
-50
| -50% | -$1.18K | ﹤0.01% | 783 |
|
|
2023
Q1 | $3.22K | Buy |
+100
| New | +$3.22K | ﹤0.01% | 815 |
|